The pharmacy benefit manager has removed reauthorization requirements for more than 140 drugs so far this year amid what ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second ...

Optum Rx is nixing reauthorization requirements for more than 60 additional medications. | The PBM giant's list of drugs includes products for behavioral health, HIV, dry eye disease, high cholesterol ...

UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.  The cuts are in addition to about 80 reauthorizations Optum Rx ...

Want to invest in artificial intelligence (AI), cloud computing, digital media, and e-commerce in one fell swoop? You could ...

Optum Rx’s push to reform its reauthorization policy comes amid broad scrutiny of prior authorization processes, where doctors need to get approval from insurers before they provide some services.

The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.

UnitedHealth stock outlook is in sharp focus as shares stay locked between $300 and $310. With Q2 earnings approaching and ...